Katy Rezvani is the Vice President and Head of the Institute for Cell Therapy Discovery and Innovation at the University of Texas MD Anderson Cancer Center in Houston.  The institute aims to accelerate the development of all forms of cell therapy, including CAR NK, CAR-T, TCR, and other approaches. Their goal is to bridge the gap between discovery and clinical application so that the most promising therapies can reach all patients as quickly and effectively as possible.  They hope to use healthy donor sources and scalable manufacturing processes to expand availability beyond specialized centers, enabling patients to benefit from these potentially life-saving approaches in more locations.